What type of study is this?

This is a Pilot-controlled trial study.

September 10, 2025JCO Global OncologyOpen Access

Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria

View Full Paper

Ask AI

Bookmark

Authors

Pilot trial evaluates a point-of-care urine metabolomics test for colorectal cancer, showing high sensitivity and patient acceptance rates.

The urine metabolomics test achieved a sensitivity of 94.5% and specificity of 81.58% for colorectal cancer.
With a high acceptance rate of 98.6%, the test indicates strong patient willingness to pay approximately $5.2 for screening.
A pilot-controlled trial involved 72 patients, comparing cases with colorectal cancer and at-risk controls in Nigeria.
The test showed potential to improve diagnostic processes and reduce referrals to colonoscopy in low-resource settings.

Adeomi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025JCO Global OncologyOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Pilot trial evaluates a point-of-care urine metabolomics test for colorectal cancer, showing high sensitivity and patient acceptance rates.

The urine metabolomics test achieved a sensitivity of 94.5% and specificity of 81.58% for colorectal cancer.
With a high acceptance rate of 98.6%, the test indicates strong patient willingness to pay approximately $5.2 for screening.
A pilot-controlled trial involved 72 patients, comparing cases with colorectal cancer and at-risk controls in Nigeria.
The test showed potential to improve diagnostic processes and reduce referrals to colonoscopy in low-resource settings.

Adeomi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark